<DOC>
	<DOCNO>NCT02734745</DOCNO>
	<brief_summary>This open-label , mono-centre , interventional study.The aim trial ass accuracy reliability flash glucose monitoring system , freestyle Libre ( Abbott , CA , USA ) , patient type 1 diabetes .</brief_summary>
	<brief_title>Accuracy Freestyle Libre</brief_title>
	<detailed_description>Objective : To assess accuracy reliability new-to-market flash glucose monitoring system , freestyle Libre ( Abbott , CA , USA ) , patient type 1 diabetes . Study design : open-label , mono-centre interventional study . Patients wear freestyle Libre 14 day home setting . There limitation food intake physical activity , patient least 7 finger-stick/days . Patients 2 visit clinical center visit 'll compare freestyle Libre value blood sample determine glucose value YSI , euglycemia glucose excursion induce hypo-hyperglycemia . Study population : 24 patient include trial . Every patient wear device 14 day home 2 visit CRC Study endpoint : main endpoint evaluation freestyle Libre accuracy real life compare glucometer value YSI glucose value ( 2 visit ) . A separate analysis perform accuracy freestyle Libre hypoglycaemic ( define blood glucose value ≤3.9 mmol/L ) hyperglycaemic area ( define blood glucose value ≥10.0 mmol/L ) . Additionally , separate analysis perform assess device performance accuracy per day device life . If patient enrol study use Dexcom G4 ( CGM ) want continue use , he/she . In case compare accuracy Libre even towards Dexcom G4 device .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Age &gt; 18 year Diagnosis diabetes mellitus type 1 ( diagnose accord World Health Organization criterion ) least one year Body Mass Index ( BMI ) &lt; 35 kg / m² Willingness wear device comply study protocol entire duration No restriction link glycated hemoglobin ( HbA1c ) Signature inform consent studyrelated procedure Pregnancy , breastfeeding , plan pregnancy , refuse use contraception study period ( female subject ) . Known allergy patch skin disinfectant use study . skin lesion , irritation , redness , edema , possible application sensor site may interfere placement device detection accuracy test result . blood donation 3 month precede study . Use drug interfere glucose metabolism ( steroid ) unless chronic therapy whose dosage remain stable last 3 month expect remain stable study period . serious medical psychological condition opinion medical team could compromise patient safety study participation . Patients enrol clinical trial . know disorder adrenal gland , pancreatic tumor , insulinomas Inability patient comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>diabetes type 1</keyword>
	<keyword>flash glucose monitoring</keyword>
</DOC>